Article on Rotaject® Technology featured in World Pharmaceutical Frontiers
The growing demand for treatments using biological drugs has created a challenge for injectable devices to deliver next-generation, high viscosity formulations all the while putting patient comfort and usability first. Building upon more than 10 years of experience with autoinjectors for highly viscous drugs, SHL’s Rotaject® technology is the ultimate solution for this challenge.
This groundbreaking technology has been featured in the 2017 spring edition of World Pharmaceutical Frontiers magazine. To learn more about the Rotaject® technology, read the full article HERE.